It gave me my life back. GLP-1s are generally considered lifelong medications, and many users regain weight after stopping
1,3 A 2025 systematic review in the International Journal of Dermatology confirmed that among GLP-1 receptor agonists, semaglutide and tirzepatide showed the highest reported incidence of hair loss, with telogen effluvium and androgenetic alopecia (AGA) identified as the predominant subtypes
This is a compelling demonstration that targeting the gut may provide a remarkable and clinically significant improvement in obesity, said Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of Fractyl Health
Starting dose Weeks 14: 0.25 mg once per week Titration schedule Weeks 58: 0.5 mg once weekly Weeks 912: Your healthcare provider will increase the dose to 1 mg once weekly
For a topical cosmetic, follow the exact product's directions and choose a time you can use it consistently